Moreover, PCAT1 was identified as an androgen late-response gene and interacted with AR and lysine-specific demethylase 1 (LSD1) upon prolonged androgen treatment to promote prostate cancer growth [30]. This evidence concerns the gene KDM1A and prostate carcinoma.